Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy

BACKGROUND: Interleukin-6 blockade (IL-6) has become a focus of therapeutic investigation for the coronavirus disease 2019 (COVID-19). METHODS: We report a case of a 34-year-old with COVID-19 pneumonia receiving an IL-6 receptor antagonist (IL-6Ra) who developed spontaneous colonic perforation. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Kristin, Hamidi, Sepehr, Chung, Augustine, Lim, Raymond J, Khanlou, Negar, Hoesterey, Daniel, Dumitras, Camelia, Adeyiga, Oladunni B, Phan-Tang, Michelle, Wang, Tisha S, Saggar, Rajan, Goldstein, Jeffrey, Belperio, John A, Dubinett, Steven M, Kim, Jocelyn T, Salehi-Rad, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543619/
https://www.ncbi.nlm.nih.gov/pubmed/33204749
http://dx.doi.org/10.1093/ofid/ofaa424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543619/
https://www.ncbi.nlm.nih.gov/pubmed/33204749
http://dx.doi.org/10.1093/ofid/ofaa424

Ejemplares similares